Veeva Commercial Summit Connects Nearly 1,500 Life Sciences Leaders Across Sales, Medical, and Marketing
PLEASANTON, Calif., April 18, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that leaders from Bristol Myers Squibb, Eli Lilly and Company, Genentech, Janssen, and Merck will be keynote speakers at the 2023 Veeva Commercial Summit on May 2-3 in Boston. Speakers from leading and emerging biopharmas will share how advancements in digital engagement, content, data, and analytics elevate commercial strategy and execution.
- Speakers from leading and emerging biopharmas will share how advancements in digital engagement, content, data, and analytics elevate commercial strategy and execution.
- One of the largest industry events in North America for commercial and medical affairs professionals, Veeva Commercial Summit will host nearly 1,500 people across more than 90 sessions.
- Veeva CEO Peter Gassner will headline the opening keynote with a bold vision to connect sales, medical, and marketing for commercial excellence.
- "The industry is transforming engagement with healthcare professionals by creating greater synergies across sales, medical, and marketing," said Paul Shawah, executive vice president at Veeva.